Skip to content
FDP

FRESH DEL MONTE PRODUCE INC

FRESH DEL MONTE PRODUCE INC Q3 FY2025 earnings call

October 29, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$0.69 / $0.28Beat +146.4%

Revenue · actual vs est

$1.02B / $1.01BBeat +0.9%
Ask about this call

Summary

Generated 2025-10-29

Management highlights

  • Delivered steady progress with gross margin expansion in fresh and value-added; pineapple program performing well. - Entered agreement to divest Mann Packing operations due to lack of profitability, believing it will strengthen margin profile. - Recorded $37 million impairment and other charges related to underperforming banana farms in Philippines. - Sold break bulk shipping vessels, continuing shift away from legacy breakbulk vessels. - Addressed industry challenge of Tropical Race 4 (TR4) disease in banana production, preparing for TR4-resistant varieties.
View in transcript ↓

Segment performance

Fresh and Value-Added Products: Net sales were $611 million. Adjusted net sales were $548 million. Gross profit was $68 million, adjusted gross profit was $76 million, gross margin increased to 11.2%, adjusted gross margin increased to 13.9%. Banana: Net sales were $358 million. Gross profit was $5 million, adjusted gross profit was $4 million, gross margin decreased to 1.3%, adjusted gross margin decreased to 1.2%. Other Products and Services: Net sales were $53 million. Gross profit was $8 million, gross margin decreased to 14.8%.

View in transcript ↓

Guidance

  • Expect net sales growth of approximately 2% year-over-year. - Fresh and value-added products segment gross margin expected 11% to 13%. - Banana segment gross margin expected to compress below historical range, approaching 4% due to cost pressures. - Other Products and Services segment gross margin expected 10% to 12%. - SG&A expenses expected $205 million to $207 million. - Full year CapEx expected $60 million to $70 million, down from prior guidance. - Net cash provided by operating activities expected to exceed prior range, closer to $190 million to $200 million.
View in transcript ↓

Risks

  • Tropical Race 4 (TR4) disease confirmed in Ecuador, escalating in Latin America, highly contagious with no cure, destabilizing regions. - Black Sigatoka disease spreading, increasing control costs for growers and putting financial strain on industry. - Mounting pressure on global banana production affecting margins and survival of growers.
View in transcript ↓

Q&A highlights

Q: Look at the fresh and value-added segment's adjusted gross margin of 13.9%, is 13% the new normal?

A: I think we're getting there, we'll be getting very close to that margin consistently.

Q: Pineapples, supply has been down, are costs up?

A: Pineapple doesn't have the same diseases as bananas, don't see significant cost increases; demand outstrips supply.

Q: Avocados, supply strong, pricing down, will it reverse?

A: Could happen in next 2-3 months, but prices won't escalate long-term; margins not impacted as much as sales.

Q: Banana consumption down in North America?

A: Seasonal, not a trend; costs up, prices not moving same direction; TR4 and Sigatoka diseases serious.

Q: Tariffs, how much added to top line?

A: It's really minimal, not much.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.69$0.28+146.4%$0.77
Revenue$1.02B$1.01B+0.9%$1.02B

Transcript

October 29, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.